Ontada Names Christine Davis Its New President

Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Christine Davis as its new president. In this role, Davis will focus on growing the business and fostering innovation, all to improve the lives of patients and win the fight against cancer. With more than 25 years of experience in the life sciences industry, Davis possesses an impressive background in oncology research and real-world data.

“Christine has a strong track record of driving significant business growth and transformation,” said Kirk Kaminsky, president of Pharmaceutical Solutions and Services at McKesson. “We’re confident she will lead the way in harnessing Ontada’s real-world data and evidence, along with McKesson’s unmatched portfolio of oncology services, to improve health outcomes for patients living with cancer.”

In her newly appointed position, Davis will advance Ontada’s real-world data and evidence services that are helping to accelerate drug development and commercialization, educate providers on new treatments, and advance precise, evidence-driven patient care. Additionally, she aims to enhance Ontada’s healthcare technology solutions to better serve oncology providers.

Previously, Davis served as the Oracle Life Sciences’ Global Head of Commercial Research & Consulting for Cerner Enviza. She worked her way into life sciences leadership while at Kantar Health, a data analytics and research company focused on oncology and rare diseases later acquired by Cerner. At Kantar, Davis led the research business and directed U.S. primary research and analytics into opportunities for growth, differentiation, and innovation on behalf of the world’s top pharmaceutical companies. She later served as global head of oncology and specialty therapeutics where she led the company’s oncology data and products business. Davis holds a master’s from Northeastern University and a BS in Nutrition and Biochemistry from Syracuse University.

“Playing an integral part in improving the lives of cancer patients is something to be proud of, and it drives me to go to work with such purpose. I am glad to be joining Ontada’s amazing team, whose members have the same passion to drive transformation and innovation in an ever-evolving field,” said Davis. “With the support of McKesson and the strength of Ontada, I see so much opportunity to bring real and powerful impact to patient lives.”